Freeman, MD, J. 2021. FDA approves Alzheimer’s drug against the recommendation of its scientific panel. Be very concerned. RRNMF Neuromuscular Journal. 2, 5 (Dec. 2021), 5–6. DOI:https://doi.org/10.17161/rrnmf.v2i5.15979.